Press Release: JAMA Network : JAMA Publishes Landmark Clinical Study Showing C2N Diagnostics' PrecivityAD2 Blood Test Markedly Improves Accuracy of AD Diagnosis in Both Primary Care and Specialized Memory Care
PrecivityAD2 Test Delivers Confirmatory Diagnostic Performance That Is Comparable To CSF Biomarkers and Amyloid PET To Identify Presence or Absence of Brain Amyloid Pathology Top-line...
Read full article »
JAMA Network is an Illinois-based media company that publishes journals of medical associations news for individuals across America.
Read more